Home > Insider Trading > Filing (0001104659-25-074388)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1657312	Verona Pharma Plc	VRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1207107	R David Ebsworth	3 More London Riverside London X0 SE1 2RE		Yes	No	No	No

Transaction Summary

Sold:	1,904 shares	Avg. Price: $13.14	Total Value: $25,025.60
Number of Shares After Transactions:	880,499 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2025-08-01	24,000	$0.00	882,403	No	4	M	Direct
Ordinary Shares	Disposition	2025-08-01	1,904	$13.14	880,499	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Stock Units	Disposition	2025-08-01	24,000	$0.00	24,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
72,000			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	617,600	Indirect	By Ebsworth GmbH

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
Excludes 617,600 Ordinary Shares represented by 77,200 ADSs that were transferred from the Reporting Person to a limited liability company of which the Reporting Person is the sole shareholder.
The sale reported in the Form 4 represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the Reporting Person's tax withholding obligation upon the vesting of the restricted stock units ("RSUs").
The price reported represents the sale price of the ADSs divided by eight (8).
Consists of (i) 880,496 Ordinary Shares represented by 110,062 ADSs and (ii) 3 Ordinary Shares.
Consists of 617,600 Ordinary Shares represented by 77,200 ADSs.
Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.